Showing results (21-30 of 259) with videos related to

Sort By:
Pageof 26
Lung Cancer (Amsterdam, Netherlands)|July 6, 2017
Optimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapyBin-Chi Liao, Chia-Chi Lin, Jih-Hsiang Lee, et al.
JTO Clinical and Research Reports|November 3, 2022
Potential Therapeutic Strategy for <i>EGFR</i>-Mutant Lung Cancer With Concomitant <i>EML4-ALK</i> Rearrangement-Combination of EGFR Tyrosine Kinase Inhibitors and ALK InhibitorsMing-Hung Huang, Jih-Hsiang Lee, Pei-Shan Hung, et al.
Therapeutic Advances in Medical Oncology|September 2, 2015
Treating patients with ALK-positive non-small cell lung cancer: latest evidence and management strategyBin-Chi Liao, Chia-Chi Lin, Jin-Yuan Shih, et al.
Cancers|April 5, 2020
The Inhibition of Wnt Restrain KRAS<sup>G12V</sup>-Driven Metastasis in Non-Small-Cell Lung CancerPei-Shan Hung, Ming-Hung Huang, Yuan-Yeh Kuo, et al.
Journal of Biomedical Science|December 4, 2016
Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitorsBin-Chi Liao, Chia-Chi Lin, Jih-Hsiang Lee, et al.
Clinical Lung Cancer|May 1, 2016
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non-Small-Cell Lung Cancer: Analysis and Literature ReviewYen-Ting Lin, Chong-Jen Yu, James Chih-Hsin Yang, et al.
Future Oncology (London, England)|August 23, 2021
Brigatinib vs alectinib in crizotinib-resistant advanced anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALTA-3)Sanjay Popat, Geoffrey Liu, Shun Lu, et al.
Clinical Lung Cancer|July 27, 2017
A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non-Small-Cell Lung CancerJames Chih-Hsin Yang, Tony Mok, Baohui Han, et al.
Expert Opinion on Drug Safety|May 24, 2016
Safety of gefitinib in non-small cell lung cancer treatmentEmily Han-Chung Hsiue, Jih-Hsiang Lee, Chia-Chi Lin, et al.
Expert Review of Molecular Diagnostics|October 15, 2016
Profile of the therascreen® EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancerEmily Han-Chung Hsiue, Jih-Hsiang Lee, Chia-Chi Lin, et al.
Pageof 26